Webinar Accordion Test

Treatment and Side Effects Health and Wellness


Treatment and Side Effects


October 17, 2018
Length
20 mins
Overview
Urinary incontinence is a common side effect that many men encounter after prostate cancer treatment. Dr. Dean Elterman explains why this occurs, who it affects, and provides expert tips on how you can better manage and treat incontinence including pelvic floor rehabilitation, medication and surgery. Dr. Elterman will also cover risk factors for urinary incontinence and recovery time.
Speaker
Dr. Dean Elterman is a Urologist and Medical Director at the Prostate Cancer Rehabilitation Clinic at Princess Margaret Cancer Centre. He has worked in the area of men’s health and survivorship at the Iris Cantor Men’s Health Center at New York Presbyterian Hospital/Weill Cornell Medical College and at the University of Toronto. Some of his current research interests include male health, voiding dysfunction and reconstruction including BPH, incontinence and sexual dysfunction (penile prosthetic surgery).
Dr. Dean Elterman
June 26, 2018
Length
19 mins
Overview
This webinar is an introduction to common drug treatments available for advanced and metastatic prostate cancer. Dr. Andrew Feifer discusses the role of testosterone and the androgen receptor in the development and growth of prostate cancer. Further, Dr. Feifer will discuss the efficacy and side effects of these drug based treatments including hormone therapy and novel therapies for castration resistant prostate cancer. 
Speaker

Dr. Andrew Feifer is a urologic oncologist at the Carlo Fidani Cancer Centre at Credit Valley Hospital where he specializes in the management of advanced castrate resistant prostate cancer. He is also an assistant professor of surgery at the University of Toronto and a faculty member at Princess Margaret University Health Network. Dr. Feifer maintains active research interest in urologic oncology outcomes, quality of care in surgery, and comparative effectiveness of new surgical techniques.

Dr. Andrew Feifer
May 29, 2018
Length
24 mins
Overview
This webinar reviews the sexual side effects that may occur after prostate cancer treatment. The risk factors of post-prostatectomy erectile dysfunction, recovery time and the benefits and limitations of available treatments will be described including the use of PDE5 inhibitors, vacuums, injections and other devices. 
Speaker
Dr. Dean Elterman is a Urologist and Medical Director at the Prostate Cancer Rehabilitation Clinic at Princess Margaret Cancer Centre. He has worked in the areas of men’s health and survivorship at the Iris Cantor Men’s Health Center at New York Presbyterian Hospital/Weill Cornell Medical College and at the University of Toronto. Some of his current research interests include male health, voiding dysfunction and reconstruction including BPH, incontinence and sexual dysfunction (penile prosthetic surgery). 
Dean Elterman
March 29, 2018
Length
23 mins
Overview
This presentation takes a closer look at a critical time within the prostate cancer disease journey between the localized and advanced disease state. Metastasis, when the cancer spreads to a different part of the body, is currently targeted by multiple treatment options available in the market. With the recent SPARTAN and PROSPER clinical trials, there are new drug developments that may target the non-metastatic castration resistant prostate cancer window to further delay metastases. Key tools and imaging options in detecting metastases are also discussed.
Speaker
Dr. Robert Hamilton is an uro-oncologic surgeon specializing in prostate cancer at the Princess Margaret Cancer Centre. He has expertise in minimally invasive surgeries, including robotic surgery. Dr. Hamilton sees patients at all different stages of prostate cancer from those at risk to this with early diagnoses to advanced disease. His research interests in prostate cancer include the study of statins and metformin in prostate cancer prevention; whether genetic markers can be used to predict who will benefit from chemoprevention; and biomarkers of prostate cancer aggressiveness.
Dr. Robert Hamilton
March 13, 2018
Length
13 mins
Overview
This short webinar will address key aspects of the impact of prostate cancer treatment on the couple. It is widely acknowledged that treatment for prostate cancer results in sexual side effects that impact both the man and his partner. These side effects often impact on the couple's relationship in a negative way and cause distress for both individuals. This webinar will address what these issues are as well as making suggestions to mitigate the effects on the couple.
Speaker
Dr. Anne Katz is a certified sexuality counselor at CancerCare Manitoba and Clinical Nurse Specialist at the Manitoba Prostate Centre. Dr. Katz is the editor of the Oncology Nursing Forum, the premier research journal of the Oncology Nursing Society. She was inducted into the American Academy of Nursing in 2014. She has educated health care providers and cancer survivors about cancer, sexuality, and survivorship around the world and is an avid blogger for ASCO Connections.
Dr. Anne Katz
February 27, 2018
Length
14 mins
Overview
Prostate cancer which has spread outside of the prostate gland is treated with systemic therapy. However, these treatments are not curative. Understanding the biological reasons for why these treatments do not work or become ineffective is important to identify better ways to treat patients. This presentation will give an overview of current understanding of why prostate cancers develop resistance to current therapies.
Speaker
Dr. Paul Toren completed his medical school at Queen's University in Kingston, Ontario and his urology residency and a clinical uro-oncology fellowship at the University of Toronto. Subsequently, he completed a two-year research fellowship at the Vancouver Prostate Centre under the mentorship of Dr. Martin Gleave. Concurrently, he enrolled in and recently completed a doctorate in experimental medicine in the laboratory of Dr. Amina Zoubeidi.  Since 2015, he works as a clinician-scientist in the Department of Surgery at Laval University, where his laboratory focuses on translational prostate cancer research.
Dr. Paul Toren
February 13, 2018
Length
28 mins
Overview
This presentation is an overview of the most common and serious side effects that are possible for men who are treated for prostate cancer.  It compares and contrasts the 4 main treatment options: surgery, low dose rate (LDR; permanent seed) brachytherapy, high dose rate (HDR: temporary seed) brachytherapy, and external beam radiotherapy (EBRT).   This is a presentation that men and their families who are still undecided as to what treatment option they prefer may find useful as it compares the risk of developing a side effect of therapy (e.g. bladder leaking, rectal bleeding, etc) between the four options.  This presentation is based on the best available data in the medical literature that a collaborative group of surgeons and oncologists agreed upon to help make sure patients are provided consistent, high quality information.
Speaker
Dr. Danny Vesprini is a Radiation Oncologist specializing in Prostate Cancer at the Sunnybrook Odette Cancer Centre, Affiliate Scientist at the Sunnybrook Research Institute and an Assistant Professor at the University of Toronto. He is one of the Principle Investigators of the Sunnybrook Active Surveillance Program, the Director of the Male Oncology Research and Education (MORE) program which focuses on men that have developed or are at a high risk of developing aggressive prostate cancer.
Dr. Danny Vesprini
January 30, 2018
Length
17 mins
Overview
The objective of this presentation is to educate patients, their partners and their loved ones to learn about radical prostatectomy as a treatment option for prostate cancer. We will discuss what the surgery entails and what to expect during the early recovery period. This will include consideration of possible complications of surgery and the need for sexual and bladder rehabilitation after surgery. Finally we will also discuss additional cancer therapies that may be offered after radical prostatectomy and how patients are followed to ensure they remain cancer free. 
Speaker
Dr. Peter Black is a Urologic Oncologist at Vancouver General Hospital, a Research Scientist at the Vancouver Prostate Centre, and Professor in the Department of Urologic Sciences at the University of British Columbia. He completed his urologic training at the University of Washington in Seattle and fellowship in urologic oncology at M.D. Anderson Cancer Center in Houston, Texas. He has a clinical subspecialty interest in prostate and bladder cancer and also a translational research program related to both cancers. 
Dr Peter Black
January 16, 2018
Length
23 mins
Overview
This presentation is focused on explaining how radiation therapy works and describes the two main methods of delivering prostate radiotherapy - brachytherapy and external beam radiotherapy. It reviews the main treatment options for low, intermediate and high risk prostate cancer, focusing on the radiotherapy options. This is a video that men and their families may find useful in explaining the different types of radiation and some of the reasons why one modality may be preferred compared to the other options.
Speaker
Dr Danny Vesprini is a Radiation Oncologist specializing in Prostate Cancer at the Sunnybrook Odette Cancer Centre, Affiliate Scientist at the Sunnybrook Research Institute and an Assistant Professor at the University of Toronto. He is one of the Principle Investigators of the Sunnybrook Active Surveillance Program, the Director of the Male Oncology Research and Education (MORE) program which focuses on men that have developed or are at a high risk of developing aggressive prostate cancer.

Health and Wellness


June 12, 2018
Length
15 mins
Overview
Research indicates that low muscle mass is a powerful and independent predictor of poorer health outcomes in the general public, particularly for those affected by cancer. In this webinar, Dr. Carla Prado discusses what leads to muscle loss, how you can prevent muscle loss with proper nutrition and what unique variables need to be considered for prostate cancer patients. Dr. Prado breaks down some of the essential nutrients for the maintenance of strong bones and muscle mass by providing simple guidelines on healthy eating.
Speaker
Dr. Carla Prado is a Registered Dietitian and an Assistant Professor at the University of Alberta, and a Campus Alberta Innovates Program (CAIP) Chair in Nutrition, Food and Health. She is also the Director of the Human Nutrition Research Unit. Dr. Prado is an expert in assessing nutritional status through the precise measurement of body composition and energy metabolism. The focus of her current research program is to develop targeted nutrition interventions for the prevention and treatment of sarcopenia in cancer.
Dr. Prado
May 15, 2018
Length
18 mins
Overview
In this webinar, Dr. Carla Prado discusses the findings of a recently conducted review on diet and lifestyle factors that were found to influence the risk of prostate cancer. A list of the strongest risk and protective factors against prostate cancer are reviewed along with strategies for maintaining a healthy lifestyle. Furthermore, current guidelines for healthy living, including Canada’s Food Guide, are broken down so they can be implemented into your daily life.
Speaker
Dr. Carla Prado is a Registered Dietitian and an Assistant Professor at the University of Alberta, and a Campus Alberta Innovates Program (CAIP) Chair in Nutrition, Food and Health. She is also the Director of the Human Nutrition Research Unit. Dr. Prado is an expert in assessing nutritional status through the precise measurement of body composition and energy metabolism. The focus of her current research program is to develop targeted nutrition interventions for the prevention and treatment of sarcopenia in cancer.
May 01, 2018
Length
19 mins
Overview
The ability to apply economic thinking when making a choice or a decision can be important partly because of limited resources which we are faced with in health care. This webinar will introduce participants to economic evaluation and its potential to help us understand the value of health intervention. Economic evaluation is a technique which enables users to compare two or more health interventions or to quantify a potential impact of a health initiative through an economic lens. Economic evaluation could provide another piece of evidence to assist various groups such as health providers, decision-makers, and policy-makers in their decision-making process.
Speaker
Dr. Wanrudee Isaranuwatchai is a Research Scientist and the Director of the Centre for Excellence in Economic Analysis Research at St. Michael’s Hospital. She is also an Assistant Professor at the Institute of Health Policy, Management and Evaluation, Dalla Lana School of Public Health at the University of Toronto, and a Health Economist at the Canadian Centre for Applied Research in Cancer Control. Her research focuses on how to apply economic evaluation in the real world setting as well as how to advance methods in economic evaluation. She has experience conducting economic evaluations using person-level data and decision modeling. She has collaborated with researchers and decision-makers in various areas to help communicate the value of health initiatives using economic evidence. Dr. Isaranuwatchai is dedicated to promoting the use of evidence in healthcare decision making.
Dr. Wanrudee Isaranuwatchai

Donate Now!




Subscribe to our free monthly e-newsletter!

* indicates required

 





 
PCC Spotlight
Rock the Road Raffle returns with its most valuable car to date

A 2018 Acura NSX to be prized by Prostate Cancer Canada and TADA at the AutoShow  
More

Prostate Cancer Canada and the Movember Foundation Announce $4M in Research Grants

Toronto, October 23, 2018 – Prostate Cancer Canada and the Movember Foundation today announced $4 million in funding to three Canadian researchers to predict how well prostate cancer will respond to treatment, based on men’s biological markers, specifically in their tumour cells and blood – opening a path to more personalized care with fewer side effects and a better chance of survival.
More

Gay and bisexual men living with prostate cancer focus of research

Vancouver, September 25, 2018 – Research funded by Prostate Cancer Canada is preparing the way to improve quality of life for men-who-have-sex-with-men (MSM)1 in the LGBTQ2+ community.
More


Click here for news archive